-dienoyl-CoA isomerase (dienoyl-CoA isomerase) (14) were purified as described.
Synthesis and Purification of Substrates -3-trans-Octenoic acid and 3-trans-tetradecenoic acid were synthesized from malonic acid and hexanal and dodecanal, respectively, according to Boxer and Linstead (15) . 3-cis-Hexenoic acid and 3-cis-octenoic acid were synthesized from 3-hexyn-1-ol and 3-octyn-1-ol, respectively, according to Stoffel and Ecker (2) . Acetoacetyl-CoA was synthesized from diketene and CoASH according to White and Jencks (16) . Crotonyl-CoA was synthesized from crotonic anhydride and CoASH according to Weeks and Wakil (17) . 2-trans,5-cis-Octadienoyl-CoA and 2-trans,5-cis-tetradecadienoyl-CoA were synthesized from 5-cisoctenoic acid and 5-cis-tetradecenoic acid according to Shoukry and Schulz (18) . Fatty acyl-CoA derivatives of all other fatty acids were prepared by the mixed anhydride method as described by Fong and Schulz (19) . All substrates for enoyl-CoA isomerase assays were purified by HPLC. A Waters µBondapak C 18 column (30 cm x 3.9 mm) attached to a Waters gradient HPLC system was used for this purpose. The absorbance of the effluent was monitored at 254 nm. Separation was achieved by linearly increasing the acetonitrile/H 2 O (9:1, v/v) content of the 50 mM ammonium phosphate buffer (pH 5.5) from 10% to 40% (for C 6 substrates), from 10% to 50% (for C 8 substrates) or from 10% to 70% (for C 14 substrates) at a flow rate of 2 ml/min. Desired fractions were collected and the organic solvent was evaporated under vacuum on a rotatory evaporator. Sep-Pak C 18 cartridges were used to concentrate the substrates after HPLC purification. After the substrates were absorbed onto the Sep-Pak columnss, they were eluted with 3 ml of methanol. Methanol was evaporated under vacuum before the substrates were redisolved in H 2 O. Concentrations of acyl-CoAs were determined spectrophotometrically by 6 quantifying CoASH with Ellman's reagent (20) after cleaving the thioester bonds with NH 2 OH at pH 7.0 (19) . at 280 nm were used to calculate rates. Enoyl-CoA isomerase activities associated with multifunctional enzyme 1 or fractions obtained by separating mitochondrial, peroxisomal, or tissue extracts were assayed by a coupled assay (21) , in which the isomerization of 35 µM 3-enoyl-CoA to 2-enoyl-CoA was coupled to the hydration of the latter compound by crotonase, the (22) was used to calculate rates. Enoyl-CoA hydratase (19), 3-hydroxyacyl-CoA dehydrogenase (21) , catalase (23) and malate dehydrogenase (24) activities were determined by established procedures. Enzymes were diluted with 50 mM KP i (pH 7.0) containing BSA (1 mg/ml). One unit of enzyme activity is defined as the amount of enzyme that catalyzes the conversion of 1 µmol of substrate to product in one minute. Protein concentrations were 7 determined as described by Bradford (25) with BSA as standard. For the kinetic characterizations of ECI and MECI with 3-enoyl-CoAs as substrates, absorbance changes at 280 nm were recorded because the basal absorbance at 263 nm was too high at elevated substrate concentrations. Rates were measured at five or six substrate concentrations and averages of three assays were used for each point. Preanalyses were performed to determine appropriate substrate and enzyme concentration ranges. Kinetic parameters (K m and V max ) were obtained by nonlinear curve fitting using the SigmaPlot 2000 program. Values of k cat , the catalytic center activity, were calculated using the reported subunit molecular masses of 40.4 kDa (7), 78.5 kDa (26) , and 29 kDa (4) for ECI, MFE 1, and MECI, respectively.
Enzyme and Protein Assays

Isolation and Purification of Subcellular Organelles from Rat
Liver -Mitochondria and a light mitochondrial fraction were prepared from rat livers as described by Nedergaard and Cannon (27) and de Duve et al. (28) , respectively. Adult male Sprague-Dawley rats (240-260 g) were used.
They were kept on a standard chow and then fasted for 24 hours before their livers were removed.
Mitochondria and peroxisomes were separated by Nycodenz density gradient centrifugation of a light mitochondrial fraction as described (29) . For this purpose, a 30% (w/v) solution of Nycodenz containing 1 mM EDTA, 5 mM Hepes (pH 7.3), and 0.1% ethanol was prepared and 21 ml of this solution were placed in a 30 ml ultracentrifuge tube on top of 1.5 ml of a 60% sucrose cushion. A density gradient was generated by centrifugation at 60,000 x g in a T865
small angle rotor on a DuPont RC70 ultracentrifuge at 4°C for 24 h. A light mitochondrial fraction (~15 mg of protein in 1.5 ml) was layered on top of the gradient followed by 1.5 ml of a cover solution of a 3-fold diluted isolation buffer containing 0.25 M sucrose, 1 mM EDTA, 0.1% ethanol, and 10 mM Tris (pH 7.4). This was followed by centrifugation at 76,000 x g for one Mops (pH 7.2) were delivered to the bottom of the tube by use of a long syringe needle. Three ml of light mitochondria (12 mg of protein/ml) were carefully layered on top of the gradient. The tubes were then centrifuged at 105,000 x g for one hour in a T865 fixed angle rotor at 4ûC using the slow acceleration and deceleration mode. Fractions were collected from the bottom after slowly inserting a thin glass tube through the bottom of the tube. Marker enzyme activities for mitochondria and peroxisomes were assayed. Peroxisomal fractions were combined and diluted 2-fold with isolation buffer before they were harvested by centrifugation at 17,500 x g for 20 min. and 400 g/l of (NH 4 ) 2 SO 4 was dialyzed overnight against buffer B before being applied to a CM cellulose column (1.5 x 8 cm) previously equilibrated with buffer B. The enzyme was eluted with a linear gradient of 100 ml of 50 mM KP i in buffer B and 100 ml of 200 mM KP i in buffer B.
Separation of Enoyl
Active fractions were combined and concentrated.
SDS-PAGE and
Immunoblotting -Samples were treated with equal volumes of SDS sample buffer and subjected to SDS-PAGE on either gradient (4-20%) or 10% ready gels (32) . Proteins were transferred to a nitrocellulose membrane by semi-dry blotting (33) using the semi-dry transfer cell from BioRad. Proteins remaining on the gel were visualized by staining with Coomassie blue. The membrane was blocked with 5% dry milk for one hour before being incubated with a 500-fold diluted rabbit antiserum for one hour. After incubating the membrane with goat anti-rabbit IgG conjugated with alkaline phosphatase for one and a half hour, it was developed with a staining mixture containing the alkaline phosphatase substrate until the antigen bands were visualized (34) .
Expression and Purification of Recombinant Peroxisomal Enoyl-CoA Isomerase -The expression
and purification of recombinant peroxisomal enoyl-CoA isomerase was done as described in principle by Geisbrecht et al. (7) . For the expression of His 6 -PECI, freshly transformed BL21 (DE3) cells harboring the pT7His-PECI plasmid were grown at 30 °C with vigorous shaking (225 rpm) for 12-14 h in 50 ml of LB media supplemented with kanamycin sulfate (25 µg/ml) and sterile 1% dextrose. After this incubation period, 7.5 ml of the preculture cell suspension were diluted into 500 ml of 2YT media containing kanamycin sulfate (25 µg/ml) and sterile 0.2% dextrose. This culture was grown with vigorous shaking at 18 °C until the A 600 reached 0.5, at which time the induction of protein expression was initiated by the addition of 1 mM isopropyl-β-D-thiogalactoside. Following growth of the induced culture for 18 h, cells were harvested and sonicated in 50 ml of buffer A (20 mM KP i (pH 7.8) containing 500 mM NaCl, and 5 mM 2-mercaptoethanol) and centrifuged at 100,000 x g for 1 hour. The supernatant was diluted to a final volume of 200 ml with buffer A and was applied at a rate of 2 ml/min to a 5 ml bed of ProBond agarose at 4 °C. The column was washed with 5 volumes of buffer A and then with 20 volumes of buffer B (20 mM KP i (pH 6.0) containing 500 mM NaCl, and 5 mM 2-mercaptoethanol). Following these washing steps, the His 6 -PECI was eluted from the bed using an imidazole step gradient in buffer B. One column volume each of buffers containing 50, 250, 350, and 500 mM imidazole was applied sequentially to the resin bed. The eluants were collected and each fraction was assayed for enoyl-CoA isomerase. Fractions containing high activities were pooled, and the His 6 -PECI present was precipitated slowly by the addition of solid ammonium sulfate to 0.4 g/ml. The activity pattern obtained with 3-cis-octenoyl-CoA as substrate was quite different. The isomerase activity present in fractions 13-18 is easily missed while the existence of two isomerase activities, presumably corresponding to MFE1 and MECI, in fractions 20 to 40 is more clearly revealed than with the 3-trans substrate. A trans/cis activity ratio of close to 2 determined for fractions 13-16 is similar to that of peroxisomal enoyl-CoA isomerase (PECI), which has a trans/cis activity ratio of 2 in contrast to MECI and MFE1 with trans/cis activity ratios below 1. 
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The presence of PECI in fractions 13-18 was confirmed by immunoblotting (data not shown).
Thus, it seems that mitochondrial long-chain enoyl-CoA isomerase is identical with PECI.
Subcellular Localization of Enoyl-CoA
Isomerases -If mitochondrial long-chain enoyl-CoA isomerase and PECI are the same enzyme, PECI must be present in both mitochondria and peroxisomes. To confirm this prediction, a light mitochondrial fraction was prepared from a rat liver homogenate and subjected to centrifugation on a Nycodenz density gradient. Fractions were assayed for catalase and malate dehydrogenase to localize peroxisomes and mitochondria, respectively. Fractions were also analyzed by immunoblotting with antibodies to MECI and PECI. The results shown in Fig. 2 demonstrate that MECI was present only in mitochondria (fractions 7-11), whereas PECI was detected in both peroxisomes (fractions 1-5) and mitochondria (fractions 7-11). Since the dual localization of PECI contradicts the reported unique association of this enzyme with peroxisomes, further confirmation was sought. For this purpose, an extract from isolated rat liver mitochondria was subjected to chromatography on hydroxylapatite. The results shown in Fig. 3 demonstrate the presence of at least two enoyl-CoA isomerases in mitochondria. The isomerase that was eluted first had a trans/cis activity ratio of approximately 2 and was recognized by an antibody to PECI. Hence, this enoyl-CoA isomerase was PECI. The enoyl-CoA isomerase corresponding to the second peak was identified as MECI because it had a trans/cis activity ratio below 1 and was detected with antibodies raised against MECI. A similar experiment was also carried out with a soluble extract from rat liver peroxisomes, which had been purified by centrifugation on an iodixanol density gradient. The results are shown in Fig. 4 . Again, two peaks of enoyl-CoA isomerase activity were detected.
The isomerase that was eluted first from the column was PECI as indicated by its trans/cis 14 activity ratio of approximately 2 and because of its recognition by antibodies to PECI. The second isomerase peak was due to MFE1 as demonstrated by immunoblotting and co-elution of enoyl-CoA isomerase, enoyl-CoA hydratase and L-3-hydroxyacyl-CoA dehydrogenase activities.
The possibility that MFE 1 may bind either MECI or PECI and thereby acquire enoyl-CoA isomerase activity prompted an experiment in which amounts of MFE 1, MECI, and PECI having equal activities of enoyl-CoA isomerase were subjected to SDS-PAGE and immunoblotting with antibodies to MECI and PECI (data not shown). The absence of MECI and PECI from the MFE 1 preparation confirmed the previous conclusion that the enoyl-CoA isomerase activity of MFE 1 is an endogenous property of this enzyme (8) . Overall, these data demonstrate that the enoyl-CoA isomerase with a preference for 3-trans-enoyl-CoAs as substrate has a dual localization in peroxisomes and mitochondria. This enzyme had previously been described as peroxisomal enoyl-CoA isomerase (PECI) and as mitochondrial long-chain enoyl-CoA isomerase.
Henceforth, this isomerase will be referred to as ∆ Table I . This enzyme is most effective in catalyzing the 3-cis→2-trans isomerization. In fact, with 3-octenoyl-CoA as substrate, the cis/trans activity ratio was observed to be 9. Although the k cat values decreased with increasing acyl chain length, the K m values also declined with the result that the catalytic efficiency of this enzyme varied little with changing acyl chain length. This general conclusion also applies to the 2,5→3,5 isomerization that is catalyzed by this isomerase almost as efficiently as the 3→2 isomerization.
ECI, the isomerase that is present in both mitochondria and peroxisomes, differs from MECI in that it exhibits a pronounced chain length dependency. Its catalytic efficiency in the 3→2 isomerizations increased 10-20 fold when the acyl chain length of the substrates was increased from 8 to 14 carbon atoms. This increased efficiency is the result of increased k cat values and lower K m values with increasing acyl chain length of the substrates. However, ECI is less effective in catalyzing the 2,5→3,5 isomerization than facilitating either the 3-trans→2-trans or 3-cis→2-trans double bond shift.
Peroxisomal MFE1 showed a different catalytic behavior than either MECI or ECI. The catalytic efficiencies determined with 3-trans-enoyl-CoA and 3-cis-enoyl-CoAs as substrates were generally lower than those observed with MECI and ECI and varied little with changes in the acyl chain length. However, MFE1 was the most effective of all three isomerases in catalyzing the 2,5→3,5 isomerization. In summary, the data presented in Tables I-III prompts the idea that in mitochondria ECI may contribute significantly to the 3-trans→2-trans isomerization, especially of long-chain intermediates formed during the β-oxidation of unsaturated fatty acids. In peroxisomes, however, ECI may be the dominant enzyme for catalyzing the 3-trans→2-trans and even 3-cis→2-trans isomerization while MFE1 may play a key role in the 2,5→3,5 isomerization.
DISCUSSION
This study demonstrates that at least two enoyl-CoA isomerases each are present in mitochondria and peroxisomes of rat liver. The surprising conclusion reached during their characterization was that one of these isomerases, henceforth referred to as ∆ 3 ,∆ 2 -enoyl-CoA isomerase or ECI, has a dual subcellular localization in mitochondria and peroxisomes. Moreover, this isomerase is identical with peroxisomal enoyl-CoA isomerase (7), PECI, and is indistinguishable from mitochondrial long-chain enoyl-CoA isomerase (5). When initially identified and characterized, PECI was shown to be located predominantly in peroxisomes of human fibroblasts (7) . It remains to be determined whether the apparent absence of this enzyme from human mitochondria is characteristic of all human cells or is a unique feature of human fibroblasts. The identification of ECI as the mitochondrial long-chain enoyl-CoA isomerase is based on the limited amount of information published about this enzyme (5) . Specifically, the immunological characterization of mitochondrial long-chain enoyl-CoA isomerase after its separation from other isomerases by chromatography on hydroxylapatite and its preference for long-chain substrates support the conclusion that this isomerase and ECI are the same enzyme. It is unclear why this enzyme was not detected in peroxisomes during the previous investigation (5) . It could be the consequence of its low activity compared to the isomerase activity of MFE1 in peroxisomes isolated from livers of clofibrate-treated rats. ECI was expected to be present in peroxisomes because the human isomerase has a C-terminal serine-lysine-leucine peroxisomal targeting sequence while the mouse enzyme has a proline-lysine-leucine signal (7) . The signal responsible for directing this enzyme to the mitochondrial matrix has not yet been identified. However, the N-terminal 16 residues of ECI are predicted to form an α-helix with amphiphilic properties.
The activities of the mitochondrial and peroxisomal enoyl-CoA isomerases were determined to analyze how the two enzymes that are present in each organelle complement each other in catalyzing the three types of enoyl-CoA isomerization reaction that take place during the β-oxidation of unsaturated fatty acids. In rat liver mitochondria, where MECI and ECI coexist, the contribution of ECI to the total 3-cis→2-trans-octenoyl-CoA isomerase activity is negligible (5% of the total activity) as illustrated by In peroxisomes, ECI also contributes significantly to the 3-trans→2-trans isomerase activity.
With 3-trans-octenoyl-CoA as a substrate, this contribution is estimated to be 40% of the total activity (see Fig. 4 ). With longer-chain β-oxidation intermediates, it is expected to be greater. Unfortunately, it is unclear which, if any, unsaturated fatty acids are degraded in peroxisomes in vivo. It is therefore not possible to make definite predictions about the contributions of ECI and MFE1 to such isomerizations even if the kinetic data for the isomerization of various β-oxidation intermediates of unsaturated and polyunsaturated fatty acids were known. Similarly, the contribution of ECI to the 3-cis→2-trans isomerizations during the peroxisomal β-oxidation of unsaturated and polyunsaturated fatty acids cannot be estimated. If long-chain and very longchain polyunsaturated fatty acids are partially degraded in peroxisomes, ECI is expected to have a major function in the necessary 3-cis→2-trans double bond isomerizations because of its preference for long-chain substrates in contrast to MFE1, which does not exhibit such specificity.
However, MFE1 will be the dominant isomerase catalyzing 2,5→3,5 isomerizations due to its high catalytic efficiency in that type of reaction.
In summary, MECI is the dominant enzyme for catalyzing 3-cis→2-trans and 2,5→3,5 isomerizations in mitochondria while ECI contributes significantly to 3-trans→2-trans isomerizations. The contributions of ECI and MFE1 in peroxisomal β-oxidation cannot be estimated due to a lack of information about the degradation of unsaturated fatty acids in this organelle. An exception is the 2,5→3,5 isomerization which in peroxisomes is most likely catalyzed by MFE1 because of its high catalytic efficiency in that type of reaction. by guest on 
